Sequence Thyself: Personalized Medicine and Therapies for the Future

Now in its 8th year, the Yale Healthcare Conference has arguably come upon its most exciting and dramatic time within the U.S. health care system. Dynamic speakers from all over the country came together in April 2012 at Yale University to question, debate, creatively think, and examine challenges within health care organizations and institutions. One of the most prominent issues concerned the aftermath of sequencing the human genome and the explosion of information concerning gene polymorphisms and biomarkers in health and disease. Clinicians, scientists, and pharmaceuticals are looking to innovative individually tailored treatments for patients. During the conference breakout session, speakers Thomas Lynch, MD, director of the Yale Cancer Center and physician-in-chief of the Smilow Cancer Hospital, and Zen Chu, MBA, co-founder of Accelerated Medical Ventures and entrepreneur-in-residence at Massachusetts Institute of Technology, provided enriching discussion on the delivery of science and genetic care of the individual.